...shares at $0.60 in a private placement to accredited investors. Rasna Therapeutics Inc. (OTCQB:RASP), New York, N.Y. Alex Himes Rasna Therapeutics Inc....

...Rasna reverse-merged with Active With Me. The combined company retained Rasna’s name and will focus on...
...a lead candidate identified by next year. Rasna did not respond in time for publication. Rasna Therapeutics Inc....

...year, the company facilitated a licensing agreement and collaboration between the IEO and London-based start-up Rasna...
...Colo. European Institute of Oncology (IEO), Milan, Italy FIRC Institute of Molecular Oncology, Milan, Italy Rasna...

...AML and sarcoma. TARGET/MARKER/PATHWAY: Lysine-specific demethylase 1 (LSD1; KDM1A ) LICENSING STATUS: Patented; licensed to Rasna...